LNSR - LENSAR Inc logo

LNSR

LENSAR Inc

LENSAR, Inc. designs and markets laser systems for cataract treatment and corneal astigmatism management. Its products include the LENSAR Laser System and the ALLY Robotic Cataract Laser System, used in surgical procedures to enhance visual outcomes.

โš•๏ธ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago โ†’$728today

Score Overview

1 Year
Score
Net Growth185.76%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-1.25%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.9
Net Growth249.98%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth67.46%
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score
Net Growth248.66%
Net Trend50%
Net Income Consistency
Rev Growth118.72%
Rev Trend83%
Revenue Consistency

See the full market ranking โ†’

LENSAR Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 26M to $ 58M and net income went from -$ 19M to -$ 34M. Revenue increased in 4 of those 5 years; net income in 2.

LENSAR Inc currently holds a 5-year HDB Score of 5.9 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 6.29โ€”
1 Year2025-08-12
$ 12.92-51.32%
5 Years2021-08-12
$ 8.64-27.20%
All Time2020-10-02
$ 9.00-30.11%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 57M$ 29M$ 13M
2025$ 58M-$ 34M$ 17M
2024$ 53M-$ 31M$ 22M
2023$ 42M-$ 14M$ 24M
2022$ 35M-$ 19M$ 14M
2021$ 34M-$ 19M$ 31M
IPO2020$ 26M-$ 19M$ 40M

Explore beyond LNSR

You're looking at LENSAR Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies